Home / Ingredients / Nopal / prickly pear cactus (Opuntia ficus-indica)

Nopal / prickly pear cactus (Opuntia ficus-indica)

Evidence reviewed: 2026-10-02

Evidence posture

Limited and heterogeneous human evidence for selected metabolic and body-composition outcomes; a clinically established weight-loss effect has not been shown.

What the evidence supports

A systematic review and meta-analysis of randomized trials found no significant effect on body weight, while some secondary body-composition, blood-pressure, and cholesterol outcomes favored Opuntia. Small controlled studies also report acute postprandial glucose effects, but preparations and doses vary substantially.

Studied context

Studies use whole or steamed nopal, cladodes, fruit-skin/cladode extracts, or other Opuntia preparations. Food-scale doses and standardized extracts are not interchangeable.

Safety context

The meta-analysis reported adverse events including gastric intolerance and flu-like symptoms. The reviewed evidence is too heterogeneous to establish a single safety profile for all concentrated extracts and doses.

Product directness

V-CONTROL lists 'nopal leaf powder' without an amount. Reviewed studies use Opuntia foods, cladodes, or characterized extracts, so formulation and dose matching to V-CONTROL cannot be established.

Products that list this ingredient/category

Primary and authoritative sources

Review-level evidence highlights

The effect of cactus pear (Opuntia ficus-indica) on body weight and cardiovascular risk factors: a systematic review and meta-analysis of randomized clinical trials (Systematic review and meta-analysis of randomized clinical trials; PMID 25837206)

Population/scope: Adults in seven eligible randomized clinical trials; five trials contributed to pooled analyses

Evidence scope: Body weight, body composition, blood pressure, and lipid outcomes

Finding: The pooled analysis did not find a significant body-weight reduction, although some secondary outcomes favored Opuntia.

Limitations: Few trials, heterogeneous designs, inconsistent reporting quality, and substantial heterogeneity for body weight limit confidence and generalizability.

Directness: Relevant human evidence ยท verified 2026-10-02

Important: Ingredient-level evidence is not proof that a finished product has the same effect. Dose, form, population, duration, and formulation must match.

For informational purposes only; not individualized medical advice.